Trial Profile
The Japan Working Group for the Assessment That the Alpha-glucosidase Inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2023
Price :
$35
*
At a glance
- Drugs Voglibose (Primary)
- Indications Glucose intolerance; Myocardial infarction
- Focus Therapeutic Use
- Acronyms ABC
- 20 Aug 2018 Status changed from completed to discontinued.
- 22 May 2018 Status has been changed to completed.
- 20 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.